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BACKGROUND: With 10.5 million people with dementia in Europe and $301 billion 
associated costs, governments face challenges organizing access to care.  
OBJECTIVE: To examine the costs related to formal and informal care use and quality of life 
for people with dementia in eight European countries, and explore the association with unmet 
needs. 
METHODS: Cross-sectional data from 451 persons with dementia and their informal 
caregivers of the Actifcare cohort study were obtained. Formal and informal care use was 
multiplied by country specific unit prices of services.  Needs were measured using the CANE 
and health-related quality of life (HRQOL) of the person with dementia (both self- and 
proxy-rated) and informal caregiver’s quality of life using EQ-5D-5L, ICECAP-O, 
DEMQOL-U and CarerQol utility scores. The association between costs and country, 
European region and unmet needs was assessed using multi-level linear regression.  
RESULTS: Self-rated EQ-5D-5L utility score was higher than proxy-rated (0.84 and 0.71 
respectively). Informal caregivers’ utility score was 0.84. Across eight countries annual mean 
costs of formal and informal care were approximately € 17,000. Unmet needs were not 
associated with annual costs of care, nor with proxy-rated HRQOL, but were associated with 
self-rated HRQOL.  
CONCLUSION: We found varying relationships between unmet needs and quality of life, 
and no association between unmet needs and care costs, although the results were sensitive to 
various factors. Future research should further investigate the relation between unmet needs, 
quality of life and costs to generate a better understanding of the effects of (un)timely access 










Dementia, caused by Alzheimer’s Disease (AD) or related diseases, forms a major health, 
social and economic global challenge of the 21st century. This has been highlighted as a 
priority by the WHO [1] as well as the European Parliament [2]. It is estimated that 10.5 
million people in Europe have dementia [3] accounting for over 22% of the total number of 
people with dementia worldwide. The total societal costs of dementia in Europe in 2015 were 
estimated at $301 billion of which $180 billion were costs of medical and social care and 
$121 billion were related to informal care [3]. 
In recent decades, various national and international organizations and collaborations such as 
Alzheimer’s Disease International and the ALCOVE project, have promoted timely 
recognition of dementia [4]. One aim of timely recognition is to improve access to services 
such as home care support that could help to maintain independence and dignity. People with 
dementia probably could stay at home longer with their families if the right support was put 
in place that addresses their needs. Most countries acknowledge that this is important and 
have policies to develop better home-based and community services and reduce 
institutionalization [5]. Research has revealed that people with dementia and their informal 
caregivers are not receiving services of the type and quality that they need, and that they 
experience difficulties accessing and working with community care services, even with a 
diagnosis of dementia [6,7]. This can put increased pressure on people with dementia and 
their families which might lead to admission to institutional care because the appropriate 
support is not in place [8]. Thus, despite the potential benefits of timely access to formal care 
and the need for these services to support informal caregivers, low rates of service use are 
still observed. In addition, there is great diversity and inequity among different health care 
and social care systems related to dementia between and within individual European 
countries [5,9,10]. The right to health care is an essential element of the Universal 
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Declaration of Human Rights [11] and of the UN Convention on the Rights of Persons with 
Disabilities [12]. It is widely acknowledged that social and economic inequalities in access to 
health care should be eliminated to meet the needs of elderly [13]. Therefore, there is a need 
for research-based studies to chart, analyze and evaluate the strengths and weaknesses of 
individual pathways to care and infrastructures. The impact of dementia on the population of 
Europe is of such a magnitude that this problem must be addressed cooperatively across 
European countries. 
Demographic changes and an aging population (and as a consequence, an increasing number 
of people with dementia), means most countries in Europe are facing great challenges in the 
current and future long-term funding of care for elderly, and people with dementia in 
particular. Due to the impact of resource use and costs of dementia on health care and social 
care systems in Europe, a proper understanding of the costs and outcomes of formal and 
informal care services utilization is fundamentally important for raising awareness, achieving 
effective prioritization, and focusing efforts to improve the lives of people with dementia and 
their caregivers.  
The overall aim of this study is to examine the costs related to formal and informal care use 
and quality of life for people with dementia in eight European countries, and explore the 
association with unmet needs. 
 
METHODS 
DESIGN AND PARTICIPANTS 
In the Actifcare (ACcess to TImely Formal care) study [14] participants with dementia and 
their informal caregivers were recruited in 2014 and 2015 in a prospective longitudinal cohort 
(baseline, 6 months and 12 months follow-up) in eight European countries (Germany (DE), 
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Ireland (IE), Italy (IT), the Netherlands (NL), Norway (NO), Portugal (PT), Sweden (SE), 
and United Kingdom (UK). Measurement instrument scores (reflecting socio-demographics, 
cognition, care use, quality of life, quality of relationship, capability, (un)met needs, 
neuropsychiatric symptoms, comorbidity, activities of daily life for the people with dementia, 
and social isolation, quality of relationship, quality of life, anxiety and depression, 
perseverance time, stress, capability, control, sense of coherence and personal and social 
resources for the informal carers) were obtained by a personal interview between the person 
with dementia, the informal caregiver and the researcher, and part of them were used for this 
study. In every country ethical approval was obtained separately and written informed 
consent was attained for both the person with dementia and the caregiver. Eligibility criteria 
were: 1) Diagnosis of dementia by DSM IV TR; 2) Clinical dementia rating score mild or 
moderate or Mini-Mental State Examination (MMSE)≤24; 3) Not receiving regular assistance 
from a paid worker with personal care on account of his/her dementia; 4) Additional 
assistance with personal care within 1 year is likely judged by a healthcare professional; 5) 
An informal caregiver willing to participate; 6) Able to complete the assessments; 7) Not 
been in care home or nursing home during the previous 6 months; 8) No alcohol-related 
dementia or Huntington’s disease. For this study, cross-sectional data from the baseline 
assessment has been used. 
 
CLINICAL MEASUREMENT INSTRUMENTS & UNMET NEEDS 
We measured dementia severity and various domains of symptoms using the following 
instruments: Mini-Mental State Examination (MMSE) [15] to reflect cognitive functioning; 
the Lawton instrumental activities of daily living scale (IADLS) [16] and the Physical Self-
Maintenance Scale (PSMS) [16] to rate activities of daily living; and the Neuropsychiatric 
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Inventory (NPI-Q) [17] to reflect neuropsychiatric symptoms. We used sum scores of these 
scales in the analysis.  
Needs were measured by the Camberwell Assessment of Need for the Elderly scale (CANE) 
[18] and scored by the researcher taking into account both the perspectives of the person with 
dementia and the informal caregiver. This interview-based questionnaire has been designed to 
map the needs (present and if so, met or unmet) and amount of help (received and needed) for 
older people over 24 categories covering psychological, physical and environmental domains. 
A total sum of met needs and a total sum of unmet needs was generated.  
 
HEALTH-RELATED QUALITY OF LIFE, WELLBEING AND UTILITY 
Quality of life and wellbeing measures relevant for health-economic evaluation included the 
EQ-5D-5L, ICECAP-O, DEMQOL-U and CarerQol, as they reflect the general health-
related, wellbeing covering dimensions ‘beyond health’, disease specific and caregiver-
related quality of life respectively, and enable the calculation of a tariff-based utility score. 
The EQ-5D-5L, ICECAP-O and DEMQOL-U of the person with dementia were all self-rated 
and proxy-rated by the informal caregiver.  
Index values were available for the EQ-5D-5L (among the participating countries in 
Actifcare: UK [19,20], NL [21], ongoing for DE and PT [22], and crosswalk set for DE, NL 
and UK [23]), the ICECAP-O (UK [24]), the DEMQOL-U and DEMQOL-PROXY-U (UK 
[25,26] both general population as well as dementia-specific population), and the CarerQol 
(NL [27]). Due to the lack of index values for the countries included in our Actifcare study, 
we used the UK index values for each country in our study. In addition, the Visual Analogue 





RESOURCE USE AND COSTING FORMAL AND INFORMAL CARE 
The Resource Utilization in Dementia (RUD) instrument [28] was used to collect data on 
resource use consumed by both the person with dementia and the informal caregiver in terms 
of frequency and intensity (number of visits or time measured in days, visits or hours) from a 
societal perspective. This included living accommodation (person with dementia), admission 
to hospital (both person with dementia and informal caregiver), hospital emergency room 
(both), care professionals (both), services (nursing, home care, food delivery, day care, 
transportation and other) (person with dementia), informal care and absenteeism from work / 
income losses associated with caring for person with dementia (informal caregiver). Resource 
use was measured over a recall period of 30 days at baseline. The RUD instrument uses 
estimates of the amount of informal care received in three domains: personal Activities of 
Daily Living (ADL), instrumental ADL and supervision (i.e. prevent dangerous events). The 
RUD instrument has been widely used and comprehensively validated [29,30].  
To calculate the resource use related costs, frequencies of resource use were multiplied by 
unit prices. Prices were based on specific national sources, publications with multi-country 
price estimates [31,32] and assumptions based on authors’ opinion (see supplemental 1), and 
transformed to Euros reflecting the year 2015. Costs were linearly extrapolated to a 1-year 
period to enable comparison with other studies. Informal care was valued according to the 
opportunity cost of which the hourly rate was reflected by the mean wage derived from 
http://ec.europa.eu/eurostat for each country in our study. This was only applied to personal 
ADL and instrumental ADL, which reflect active caring time. To reflect the mix of retired 





Summary statistics were provided for demographics and outcomes in terms of disease 
severity, quality of life, resource use and corresponding costs of the consumed care resources 
of the person with dementia and their informal caregivers. For resource use, both the 
percentage users and the mean frequencies of resource use among the users were estimated. 
Costs were bootstrapped using 5000 replicates and the 2.5th and 97.5th percentile of the mean 
was estimated using the statistical software R3.3.1 [34]. 
Missing demographic, clinical, HRQOL and care usage were item-wise deleted (e.g. when a 
participant had missing visits to a neurologist, this participant was omitted for the calculation 
of mean care professional usage but not for mean accommodation). For the calculation of 
costs, frequencies of resource use were imputed across the entire dataset by multiple 
imputation using the STATA13 chained equations and predictive mean matching command 
to construct an imputation model with age and gender of both the person with dementia and 
informal caregiver, MMSE, IADLS, PSMS and NPI, CANE, quality of life as well as RUD 
items as predictor variables. Ten imputed datasets were generated. The mean of all 10 
imputed datasets was used only for describing the costs by country and category of number of 
unmet needs (see below).  
Country differences regarding demographics, disease severity and quality of life were 
assessed using ANOVA and Chi-square tests. A multivariate regression model was used to 
assess cost differences between countries and country regions (Northern: Norway and 
Sweden; Western: Germany, Ireland, Netherlands and United Kingdom; Southern: Italy and 
Portugal). To ensure the regression assumption of linearity, costs were transformed using the 
natural log with a data-driven optimal correction factor. These were ln(costs + 1087) when 
using country-specific unit prices and ln(costs + 1621) when using mean unit prices. Person 
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with dementia demographic (age and gender) and disease severity (MMSE, IADLS, PSMS 
and NPI) variables were included in both models as covariates.  
The association between natural log transformed costs and unmet needs was assessed using 
regression. The number of unmet needs according to the CANE instrument was categorized 
into 0, 1-2 and more than 2 based on expert opinion (AW, AS, RH). A mixed model was used 
with country as random factor to adjust for country differences. The number of needs was 
considered a confounder and was therefore included as a covariate. It was also assumed to 
reflect the effects of age, comorbidities and functional dependency. Similarly, the association 
between categorized unmet needs and both self- and proxy-rated EQ-5D-5L was assessed. In 
all analyses P<0.05 was considered significant.   
 
SENSITIVITY ANALYSIS 
We explored various alternative options in sensitivity analyses. The mean of the country-
specific unit prices was used to exclude any differences between countries in how the unit 
price was build-up. In two other options, the price from the country with the lowest (Italy) 
and highest (Norway) mean price was applied to all countries. For informal care on personal 
ADL and instrumental ADL, a proxy good cost unit price was used reflecting the mean wage 
for a person in the social care sector (also known as the replacement cost approach). 
Furthermore, the costs of informal care supervision were included in an option by applying 
the same unit prices as for personal ADL and instrumental ADL. Two imputation options of 
case-wise deletion and imputation with 0 were applied on resource use.  
The regression analyses on costs were alternatively run using mean unit prices instead of 
country-specific unit prices. As an alternative to categorizing the number of unmet needs, it 





In total 451 people with dementia and their informal caregivers (dyads) participated in the 
Actifcare study and were eligible for these analyses. The mean age of people with dementia 
was 78 (SD: 8) and 55% were female (see table 1). Almost all (94%) lived at home and a few 
in non-dementia-specific intermediate forms of accommodation, with a large proportion 
living with their informal caregiver (72%). Their mean MMSE was 19.0 (SD: 5.0) reflecting 
a cognitive deficit in the mild to moderate dementia range. The mean age of informal 
caregivers was 66 (SD: 13) and they were mainly spouses/partners (64%) or sons/daughters 
(32%) of the person with dementia. All demographic characteristics differed significantly 
between countries, except for the gender of the informal caregiver (see table 1). The missing 
data for each of the scales was less than 8% (see supplemental 2).  
Mean quality of life and wellbeing scores are presented in table 2. The mean health-related 
quality of life of the people with dementia was 0.84 (self-rated) and 0.71 (proxy-rated). A 
higher self-rated score was also observed for the EQ-5D VAS (72 versus 61), wellbeing 
measured by the ICECAP-O (0.82 versus 0.69 on a 0-1 scale), and DEMQOL-U (0.87 versus 
0.74). Paired t-tests found significant differences for all self- and proxy ratings. Informal 
caregivers on average scored their own health-related quality of life 0.84, wellbeing 0.78 and 
CarerQol 0.76. All except the informal caregiver’s EQ-5D-5L utility score significantly 
differed between countries. Person with dementia self-reported quality of life (excluding EQ-
5D VAS) significantly differed by reported unmet need; those having 3 or more unmet needs 
reported significantly lower quality of life. These differences were, however, small (see table 
3). There was a similar pattern for the proxy ratings and the carer self-report, although fewer 
of the differences were significant.  
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Extrapolated annual mean costs related to resource use were € 17,296 across countries. About 
half of these costs were related to informal care (€ 9,497). Highest total costs occurred in 
Ireland (€ 23,737) and lowest in Portugal (€ 6,222) (see figure 1 and table 4). Costs relating 
to accommodation were highest in the Netherlands, and Ireland had the highest costs for 
hospital admission and emergency for participants. Portugal had low informal care costs, 
which was mainly related to the low unit price as resource use was near the mean usage in the 
whole sample across eight countries. Supplemental 3 provides an overview of the mean 
reported resources used in the 30 days before the baseline assessment. 
Transformed costs significantly differed between countries (p<0.001) as well as between 
country regions (p<0.001) after correcting for participants’ demographic and disease severity 
characteristics.  
Categorized unmet needs (see table 3) were not significantly associated with transformed 
costs (p=0.180), were also not significantly related to the proxy-rated EQ-5D-5L utility score 
of the person with dementia (p=0.426), but were significantly related to the self-rated EQ-5D-
5L (p=0.009).  
 
SENSITIVITY ANALYSIS 
Sensitivity analysis showed a variation in mean total cost of service use (formal and informal 
care) when relying on different assumptions regarding unit prices, cost categories and 
handling missing data (see supplemental 4). Although mean total cost of service use between 
countries varied, the impact of using mean of all country unit prices instead of country-
specific unit prices was relatively small. The value assigned to informal care had a large 
impact on mean total cost of formal and informal care. The imputation methods case-wise 
deletion affected the mean total costs of Germany. This can be explained by the fact that a 
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large proportion of the German participants had one or only a few missing responses to one 
of the various items of the care use questionnaire, requiring the case-wise deleting of these 
participants from this particular scenario of the sensitivity analysis (opposite to a relatively 
small proportion of participants with missing responses in the other country samples) (see 
supplemental 2).  
Country differences in costs were also significant when relying on mean unit prices 
(p=0.021) but country region differences were not (p=0.603).  
Regarding unmet needs, they were significant when relying on mean unit prices (p=0.028). 
Unmet needs included on a continuous scale were not significant when relying on country-
specific unit prices (p=0.053) but were when relying on mean unit prices (p=0.014). Unmet 
needs on a continuous scale were not significantly related both to proxy- (p<0.129) or self-
rated (p<0.072) quality of life. Residuals in the analyses were good (costs) to moderately 
(quality of life) normally distributed. 
 
DISCUSSION 
SUMMARY OF FINDINGS 
The annual mean costs in eight countries in Northern, Western and Southern European were 
€ 17,296 in a convenience sample of people with dementia and their informal caregivers, but 
it differed between countries. The main cost driver was informal care (55% of the total costs). 
Persons with dementia rated their health-related quality of life higher than their proxies. 
Unmet needs were not associated to transformed costs or health-related quality of life rated 
by the informal caregivers of the people with dementia.  
17 
 
The costs differed between countries in terms of the amount of care provided, its economic 
value reflected by the unit price and its corresponding costs. Although the included countries 
in this study reflect European welfare state systems, there are nevertheless differences in how 
care is organized and financed. The costs and outcomes that are presented seem to reflect the 
expected differences in terms of high consumption of formal care in Northern and Western 
Europe, but not in terms of informal care. Compared to all countries mean usage, Portugal 
and Italy had slightly lower and slightly higher informal care use respectively. In Portugal, 
this could be explained by the low unit price as well as the reported use of the services of a 
“housekeeper” (mean 17.9 hours in 30 days), which may have substituted or prevented 
informal care in this sample. Some differences between the division of care over the various 
care sectors might be due to outliers, as for example in Ireland one person reported all days of 
the recall period spent in a hospital corresponding to an impact of € 6,667 on the mean total 
costs in Ireland (€ 530 on the mean total costs of all countries; this is on the border of the 2.5 
and 97.5 percentile bootstrap interval). The case was not excluded since it was a justified 
observation and was therefore explored in the sensitivity analyses. Also, unobserved 
demographic or disease severity characteristics that are associated to costs or HRQOL could 
have differed between the country-specific samples, which could have biased the country 
differences. 
Mean annual care costs of AD-type dementia were estimated € 6,063 in Northern Europe, € 
8,279 in Western Europe and € 7,049 in Southern Europe in the ICTUS study [35]. Our 
estimates were higher and could mainly be explained by the exclusion of medical care 
consumption by the informal caregiver, the difference in population due to recently 
diagnosed patients at a memory clinic (with a large proportion of very mild AD), and the 
lower unit price applied to informal care in the ICTUS study. Similar to the ICTUS study we 
observed lower medical care in Southern Europe, but we did not observe higher informal care 
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for the possible reasons explained above. The total annual costs in a subsample of mild and 
moderate AD-type dementia in the GERAS study [36] were €20,376 in three Western 
European countries. This was similar to our findings as well as the proportion of costs in the 
costs categories in the overlapping countries Germany and United Kingdom. The sample 
characteristics in terms of demographics and disease severity also were similar, as well as the 
unit prices and included costs components. However, specific to this study were two of the 
inclusion criteria (exclusion of persons receiving regular paid assistance; including persons 
who will likely receive formal personal care within 1 year), of which the first could have 
resulted in a lower estimate and the second in a higher estimate of care use compared to the 
typical studied secondary memory clinic population with a recent diagnosis of AD-type 
dementia.  
Compared with Parkinson’s disease, our sample reflects a relatively large proportion of costs 
related to non-medical costs (informal care and social services) and a relatively small 
proportion of direct medical costs, which has been more equally distributed in Parkinson’s 
disease [37–39]. 
The proxy-rated person with dementia’s quality of life was lower than the person with 
dementia’s self-rating (with somewhat higher proportions of missing data for the self-rated 
observations, see supplemental 2). This has been shown earlier [40] and highlights the issue 
of the rater’s perspective. People with mild and moderate dementia can to a great extent 
express their views. However, as the disease progresses, awareness of memory and functional 
limitations decreases [41]. Awareness was also found to be associated with sociodemographic 
characteristics and the relation between the person with dementia and the informal caregiver 
[42]. If a person with dementia rates aspects of quality of life as “good or high level” 
(domains of quality of life may include cognitive but also functional aspects) but a proxy has 
a different perspective and therefore rates them as “worse or low level”, one could wonder 
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which perspective (patient, proxy or presenting both) best fits the research question of a 
particular study. Various studies have indicated differences between both perspectives [43], 
which suggested further research is needed.  
Costs could not be explained by the number of unmet needs in the main analysis, for which 
various explanations are plausible. Costs were based on care usage in the 30-day period 
before the observation of unmet needs. Although a relatively short time period, care use could 
have affected needs. Also, the use of medical and informal care could not have been a 
consequence of the unmet needs (e.g. care related to crisis situations because a lack of 
supervision or day care activities). The association also seemed to be dependent on the unit 
price, as the sensitivity analyses indicated a significant association when relying on mean unit 
prices. The analysis was, however, subject to limited power since at baseline of the Actifcare 
study persons using dementia-related formal care were excluded from participation, leaving 
limited possibilities to observe so-called dementia-related consequential care. The impact of 
unmet needs on service use would be expected to emerge in longitudinal analyses, especially 
in situations where informal care is not successful in meeting the unmet need. HRQOL was 
also not related to unmet needs, although these results were dependent on who rated the 
HRQOL (sensitive to proxy- versus self-rating). Also it unexpectedly increased from 0 to 1 or 
2 unmet needs (+0.03) and decreased from 1 or 2 to 3 or more (-0.07). Subgroup differences 
in terms of demographics and the particular needs that are unmet could be confounding 
factors in this association, or there could be a tipping point where unmet needs begin to 





For the regression analysis on costs predicted by unmet needs, the care-related costs were 
observed earlier in time than the unmet needs. The care use in this period could have affected 
the needs. However, given the relative short time period of 30 days and our expectation that 
care use and needs are relatively stable over this time period, we did not expect this to have a 
significant impact on the results.  
This analysis was based on a specific sample of home-dwelling persons with mild or 
moderate dementia. The people with dementia in this study were living at home at baseline 
and were selected based on their probability of needing formal care within 1 year. They do 
not represent the general population with dementia and thus it is not possible to generalize 
our results to reflect the cost of illness of the national dementia population in each country. 
The representativeness was further limited by the relatively small country-specific sample 
sizes (ranging from 43 to 76), which made them prone to coincidental effects on the 
inclusion. The descriptive statistics were not adjusted for possible country differences and 
should therefore be interpreted with caution. Also, the imputation procedure did not adjust for 
country differences. Although alternative imputation strategies have been explored and did 
not result in relevant differences in costs, it could have had an impact on the results. 
Countries in Eastern Europe were not included in the Actifcare project. These countries can 
be expected to differ from the other regions.  
Costs related to medication use were not included and therefore the total care costs are 
underestimated. However, these costs were likely to be small as they reflected less than 10% 
of the total costs in the ICTUS study [35]. The costs due to productivity loss were partly 
double-counted with the costs related to hours providing informal care, which slightly 
overestimated the total costs. Although rescaling costs observed over a 30-day period to 1 
year does not affect the significance in the regression analysis, these might not reflect the 
actual 1-year costs.  
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The economic valuing of informal care is a complicated and controversial topic [44]. A 
standard is completely lacking and thus transparency regarding how informal care is 
quantified and valued is crucial, as is varying uncertainties in a sensitivity analysis.  
Country-specific prices were likely subject to methodological differences. Among them was a 
difference in how the price was built up (e.g. hotel costs in- or excluded in hospital care 
price). The location at which prices are published varied and the language was often non-
English, which increased the likelihood of missing important sources. Some sources reported 
a price per hospital or care home admission without clear information on the mean days of an 
admission, making it difficult to transform it into the format of the RUD questionnaire. There 
were also discrepancies between the designation or description of the care type by the RUD 
questionnaire and by the source reporting the unit price (e.g. prices reported for diagnosis-
related-groups), as well as differences in the year at which a price was derived (see 
supplemental 1 and 5 for details). These limitations strongly indicate the need to harmonize 
the methods to calculate care unit prices in Europe and make them easily accessible (such as 
aimed by the PECUNIA project www.pecunia-project.eu).  
Some of the uncertainties due to the limitations were taken into account in the sensitivity 
analysis to reflect their impact on the total costs and results of the analyses. In explorative 
post-hoc analyses the cut-off for low and high numbers of unmet needs was ranged between 1 
and 10 but did not result in any significant relation between categorized unmet needs and care 
costs. However, various results were significant for p<0.20 and omitting participants with 
high number of unmet needs (more than 10) resulted in a significant relation between unmet 
needs and costs as well as when included on a continuous scale, indicating this relation was 
sensitive to the method and unstable, and therewith subject for future research. The post-hoc 
analysis and sensitivity analysis were subject to multiple testing for which was not adjusted. 




RECOMMENDATIONS FOR FUTURE RESEARCH 
The sensitivity of the associations between unmet needs and costs, and unmet needs and 
HRQOL to the unit prices, rater and outcome scale indicates there might be a potential for 
efforts on improving the access to care to improve the quality of life for people with dementia 
and reduce their costs. However, further research into this topic is crucial to explore 
subgroups with a strong association between unmet needs and costs or unmet needs and 
HRQOL (potentially a combination of the living situation and presence of behavioral or 
cognitive symptoms). Such knowledge could help to develop person-tailored interventions 
that can be applied to a subgroup with a high potential for improving their HRQOL.  
In addition, longitudinal data is important to reflect upon the timing of care (longer enduring 
unmet needs might have a larger impact on care use and HRQOL) and the type of need 
(unmet need on neuropsychiatric symptoms might weigh heavier on for example informal 
caregiver time and HRQOL than an unmet need on compliance to medication). Furthermore, 
details on the degree of unmet needs and the proportion of a need already being met by 
informal care could be used to increase our understanding of the effects of unmet needs on 
costs and HRQOL. The potential effect is large as mean annual costs have been estimated to 
be € 29,148 and € 53,892 in a population consuming professional home care and institutional 
long-term nursing respectively [45], which is significantly higher than the costs estimated in 
our population of persons not consuming professional care. These topics, however, fell 






Our eight country European study, one of the largest comparative studies in dementia care, 
did not find a relationship between unmet needs and quality of life, and not between unmet 
needs and care costs, although the results were sensitive to various factors. Given the 
interaction between formal and informal care future research should unravel the relationship 
between unmet needs, quality of life and costs to generate a better understanding of the 
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 North North West West West West South South  
Person with dementia   
   
  
  
Age* 78 (7) 80 (7) 77 (9) 74 (9) 76 (8) 79 (8) 79 (8) 77 (6) 78 (8) 
Female gender* 60% 52% 42% 51% 57% 43% 70% 62% 55% 
Education (years)* 11 (3) 9 (3) 12 (3) 12 (4) 11 (4) 11 (2) 7 (4) 6 (6) 10 (4) 
Marital status          
     Married 70% 72% 73% 67% 78% 48% 58% 76% 69% 
     Widowed 20% 21% 21% 28% 16% 34% 40% 18% 24% 
     Other 10% 7% 6% 5% 6% 18% 2% 6% 7% 
Lives in own home* 95% 99% 98% 100% 94% 100% 91% 82% 94% 
Lives together with carer* 73% 82% 77% 58% 80% 52% 55% 85% 72% 
   




person with dementia 
  
   
  
  
MMSE (0-30)* 19.1 (4.9) 20.4 (4.4) 20.2 (5.9) 20.3 (5.4) 19.8 (4.3) 18.8 (5.4) 16.9 (3.7) 17.8 (4.8) 19.0 (5.0) 
IADLS (0-8)* 4.2 (1.8) 3.0 (2.0) 3.3 (2.0) 3.4 (2.6) 3.9 (1.7) 3.0 (1.7) 3.0 (1.8) 3.7 (2.0) 3.4 (2.0) 
PSMS (0-6)* 4.5 (1.3) 4.0 (1.8) 3.2 (2.1) 3.4 (2.0) 4.1 (1.8) 3.4 (1.8) 2.8 (1.8) 3.7 (2.0) 3.6 (1.9) 
NPI (0-30)* 8.8 (5.1) 5.6 (4.4) 6.1 (4.7) 8.9 (5.5) 9.1 (6.5) 7.9 (5.5) 8.7 (5.8) 6.8 (5.5) 7.7 (5.5) 
CANE met needs (0-24)* 8.6 (2.3) 4.5 (2.1) 10.0 (4.5) 8.3 (3.6) 7.2 (2.5) 9.2 (3.4) 9.0 (2.0) 8.2 (2.8) 8.2 (3.3) 
CANE unmet needs (0-24)* 2.2 (1.5) 0.1 (0.6) 1.4 (2.0) 3.3 (2.3) 2.6 (2.5) 1.7 (1.7) 1.7 (1.9) 1.2 (1.7) 1.8 (2.0) 
   
   
  
  
Informal caregiver   
   
  
  
Age* 70 (13) 67 (12) 69 (12) 58 (15) 69 (9) 70 (10) 60 (13) 65 (15) 66 (13) 
Female gender 58% 58% 73% 77% 55% 72% 72% 67% 67% 
Education (years)* 12 (4) 11 (3) 14 (4) 15 (4) 12 (3) 12 (3) 11 (4) 9 (6) 12 (4) 
Marital status*   
   
  
  
     Single/widowed 8% 8% 10% 16% 10% 14% 15% 14% 12% 
     Married/partnership/co-
habiting 
92% 92% 88% 84% 90% 86% 85% 86% 88% 
Relation to person with 
dementia* 
  
   
  
  
     Spouse/partner 73% 76% 75% 53% 75% 52% 38% 61% 64% 
     Son/daughter (in law) 25% 22% 21% 42% 20% 40% 57% 35% 32% 
     Other 2% 1% 4% 5% 6% 8% 6% 5% 4% 
Abbreviations: CANE, Camberwell Assessment of Need for the Elderly; IADLS, 
instrumental activities of daily living scale; MMSE, Mini-Mental State Examination; NPI, 
neuropsychiatric inventory; PSMS, Physical Self-Maintenance scale.  
The range (best possible score underlined) of the MMSE is 0 to 30, IADLS 0 to 8, PSMS 0 to 
6, NPI 0 to 30, CANE met needs 0 to 24, and CANE unmet needs 0 to 24.  


























































North North West West West West South South 
 
Person with dementia   
   
  
  
EQ-5D-5L utility (S)* 0.90 (0.14) 0.76 (0.20) 0.81 (0.16) 0.89 (0.08) 0.87 (0.21) 0.81 (0.16) 0.83 (0.15) 0.83 (0.15) 0.84 (0.16) 
EQ-5D-5L utility (P)* 0.72 (0.15) 0.63 (0.21) 0.65 (0.23) 0.74 (0.20) 0.76 (0.21) 0.70 (0.23) 0.72 (0.16) 0.76 (0.18) 0.71 (0.20) 
EQ-5D VAS (S)* 75 (18) 63 (18) 72 (18) 76 (14) 75 (19) 72 (20) 74 (22) 70 (19) 72 (19) 
EQ-5D VAS (P)* 56 (19) 52 (19) 60 (18) 67 (20) 71 (15) 66 (17) 65 (21) 56 (20) 61 (20) 
ICECAP-O utility (S)* 0.89 (0.12) 0.77 (0.14) 0.80 (0.14) 0.92 (0.08) 0.85 (0.14) 0.83 (0.11) 0.82 (0.17) 0.73 (0.18) 0.82 (0.15) 
ICECAP-O utility (P)* 0.72 (0.14) 0.65 (0.15) 0.68 (0.18) 0.76 (0.18) 0.72 (0.17) 0.72 (0.16) 0.66 (0.20) 0.65 (0.17) 0.69 (0.17) 
DEMQOL-U utility (S)* 0.90 (0.07) 0.89 (0.07) 0.85 (0.11) 0.92 (0.06) 0.89 (0.09) 0.87 (0.09) 0.85 (0.12) 0.81 (0.13) 0.87 (0.10) 
DEMQOL-U utility (P)* 0.72 (0.13) 0.69 (0.13) 0.77 (0.11) 0.76 (0.13) 0.76 (0.14) 0.74 (0.11) 0.77 (0.14) 0.73 (0.15) 0.74 (0.13)  
  
   
  
  
Informal caregiver   
   
  
  
EQ-5D-5L utility 0.84 (0.20) 0.81 (0.18) 0.86 (0.17) 0.85 (0.15) 0.85 (0.20) 0.81 (0.15) 0.87 (0.10) 0.84 (0.18) 0.84 (0.17) 
EQ-5D VAS* 70 (20) 69 (16) 71 (18) 79 (16) 74 (15) 73 (17) 74 (19) 66 (20) 72 (18) 
ICECAP-O utility* 0.83 (0.11) 0.82 (0.14) 0.73 (0.20) 0.78 (0.18) 0.81 (0.13) 0.77 (0.14) 0.77 (0.16) 0.75 (0.16) 0.78 (0.16) 
CarerQol utility* 0.80 (0.13) 0.80 (0.17) 0.72 (0.16) 0.73 (0.21) 0.74 (0.19) 0.74 (0.16) 0.73 (0.15) 0.79 (0.16) 0.76 (0.17) 
CarerQol VAS* 5.6 (2.1) 7.0 (1.7) 6.1 (2.0) 6.9 (1.7) 7.0 (1.6) 6.5 (1.7) 6.0 (1.8) 6.1 (2.2) 6.4 (1.9) 
Abbreviations: P, proxy-rated; S, self-rated; VAS, visual analogue scale. 
The range of the EQ-5D utility is -0.208 to 1, EQ-5D-VAS is 0 to 100, ICECAP-O utility is 0 to 1, DEMQOL utility self-rated is 0.243 to 0.986, 
the DEMQOL utility proxy-rated is 0.363 to 0.937, the CarerQol utility is 0 to 1.002, and the CarerQol VAS is 0 to 10. Higher estimate 
reflecting a better condition. The lowest utility scores reflected the worse imaginable health state and the highest utility scores the best 
imaginable health state.  
* p-value < 0.05 for country-differences.  
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Table 3: Mean (and standard deviation or 2.5 and 97.5 percentile bootstrap interval) of demographic, quality of life and costs by unmet needs 


























































Person with dementia 
    
Age 78 (7) 77 (8) 78 (9) 78 (8) 
Female gender 52% 59% 53% 55% 
Lives together with caregiver 72% 73% 70% 72%      
Clinical characteristics person with dementia 
    
MMSE (0-30) 19.3 (4.8) 18.4 (5.2) 19.1 (5.1) 18.9 (5.1) 
IADLS (0-8) 3.5 (2.0) 3.6 (2.0) 3.2 (2.0) 3.4 (2.0) 
PSMS (0-6) 3.8 (1.9) 3.8 (1.8) 3.4 (2.0) 3.7 (1.9) 
NPI (0-30) 5.7 (4.4) 7.8 (5.4) 10.1 (6.0) 7.8 (5.6) 
CANE met needs (0-24) 7.7 (3.8) 8.8 (2.9) 7.7 (2.9) 8.1 (3.3) 
CANE unmet needs (0-24) 0.0 (0.0) 1.4 (0.5) 4.5 (1.9) 1.8 (2.1)      
Informal caregiver 
    
Age 68 (13) 66 (13) 66 (14) 66 (13) 
Female gender 66% 67% 67% 67%      
Person with dementia 
    
EQ-5D-5L utility (S)* 0.83 (0.16) 0.88 (0.13) 0.81 (0.19) 0.84 (0.16) 
EQ-5D-5L utility (P)* 0.72 (0.20) 0.75 (0.19) 0.68 (0.20) 0.72 (0.20) 
EQ-5D VAS (S) 72 (18) 74 (19) 71 (20) 72 (19) 
EQ-5D VAS (P) 62 (19) 63 (20) 58 (20) 61 (20) 
ICECAP-O utility (S)* 0.83 (0.12) 0.86 (0.14) 0.79 (0.18) 0.83 (0.15) 
ICECAP-O utility (P)* 0.71 (0.17) 0.72 (0.15) 0.65 (0.18) 0.69 (0.17) 
DEMQOL-U utility (S)* 0.89 (0.07) 0.88 (0.09) 0.85 (0.13) 0.87 (0.10) 
DEMQOL-U utility (P) 0.75 (0.13) 0.74 (0.13) 0.72 (0.13) 0.74 (0.13)      
Informal caregiver 
    
EQ-5D-5L utility 0.84 (0.15) 0.85 (0.18) 0.82 (0.18) 0.84 (0.17) 
EQ-5D VAS 72 (17) 73 (19) 70 (19) 72 (18) 
ICECAP-O utility* 0.79 (0.15) 0.80 (0.14) 0.76 (0.17) 0.78 (0.16) 
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CarerQol utility* 0.79 (0.15) 0.77 (0.17) 0.72 (0.17) 0.76 (0.17)      
Person with dementia 
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Abbreviations: P, proxy-rated; S, self-rated; VAS, visual analogue scale. 
The utility ranges are 0-1, EQ-5D-VAS is 0-100 and the CarerQol VAS is 0-10, with higher estimate reflecting a better condition. 
 * p-value < 0.05 
1 accommodation response options included accommodation in own home, intermediate, dementia specific, long-term institutional, and other 
(see supplemental 3); 2 professional response options included general practitioner, geriatrician, neurologist, psychiatrist, physiotherapist, 
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occupational therapist, social worker, psychologist, and other; 3 services response options included district nurse, home aid, food delivery, day 




Table 4: Mean (2.5 and 97.5 percentile bootstrap interval) societal costs in Euro (2015) of 30-day resource use prior to the baseline assessment 



















































 North North West West West West South South 
 
Person with dementia   
















































































          































































































































































































































































   
  
  
own home day 0 0 0 0 0 0 0 0 0 
Intermediate forms day 22 140 58 79 134 111 27 40 76 
Dementia specific residential day 252 180 116 157 168 111 53 37 141 
Long-term institutional care day 249 180 116 157 168 111 53 90 141 
Other day 0 0 0 0 0 0 0 0 0   
  
   
  
  
Admission to hospital 
 
  
   
  
  
Geriatric night 1462 518 255 841 477 388 427 b 576 
Psychiatric night 1462 518 523 352 477 388 427 191 549 
Internal medicine night 1462 518 343 841 477 388 427 884 587 
Surgery night 1462 518 861 841 406 388 427 884 643 
Neurology night 1462 518 496 841 396 388 427 1361 596 
General ward night 1462 518 496 841 477 388 427 884 606 
Other night 1462 518 496 841 477 388 427 884 606   
  
   
  
  
Emergency room visit 235 324 54 275 260 83 79 84 174   
  






   
  
  
General practitioner visit 38 124 19 52 33 48 25 34 47 
Geriatrician visit 139 425 65 162 91 47 78 b 134 
Neurologist visit 139 425 65 162 99 47 78 65 135 
Psychiatrist visit 139 425 19 162 91 63 78 65 130 
Physiotherapist visit 75 101 28 29 33 25 21 16 41 
Occupational therapist visit 75 101 28 29 33 28 21 16 41 
Social worker visit 92 101 35 29 65 36 21 16 49 
Psychologist visit 156 101 60 29 64 54 21 16 63 
Other visit 139 425 65 162 91 47 78 65 134   
  











District nurse or equivalent  hour 74 47 13 33 73 32 44 33 44 
Home aid/orderly hour 60 47 5 19 50 28 20 17 31 
Food delivery visit 9 24 11 7 5 7 5 4 9 
Day Care hour 17 14 21 17 11 15 16 13 15 
Transportation  visit 32 31 4 18 4 29 1 1 15 
Other hour 60 47 5 19 50 28 20 7 31   
  






   
  
  
Informal care instrumental ADL hour 11 6 6 8 7 7 5 3 7 
Informal care personal ADL hour 11 6 6 8 7 7 5 3 7 
Informal care supervision hour 0 0 0 0 0 0 0 0 0   
  






   
  
  
Mean wage hour 30 18 18 23 19 19 16 8 19 
Abbreviations: ADL, activities of daily living 
Living accommodation ‘other’ mainly contained holiday at relatives’ home or hotel; Services ‘other’ mainly contained housekeeper or low level 
home care help.  
Unit prices were obtained from various international and national sources. All prices were converted to Euros and to 2015 values using annual 
exchange rates and Harmonised Indices of Consumer Prices from http://ec.europa.eu/eurostat. Details on unit prices, sources and assumptions 
can be found in supplemental 5.  
a Updated prices for Portugal were available in various Administrative rules, however, due to issues with transforming prices to the items of the 
RUD questionnaire in various cases prices reported by Luengo-Frenandez et al. [32] have been used as well as assumptions based on authors’ 
opinions.  
b Type of care not yet applicable/available in this country at time of fieldwork.   
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SUPPLEMENTAL 2: missing data 
Applies to 
(rater) 
Item Norway Sweden Germany Ireland Netherlands United 
Kingdom 
Italy Portugal All 
PwD Age 
         
PwD Gender 
         
IC Age 
         
IC Gender 
         
PwD MMSE 8 (1.8%) 
 







2 (0.4%) 2 (0.4%) 
  
6 (1.3%) 




1 (0.2%) 2 (0.4%) 
  
6 (1.3%) 




2 (0.4%) 3 (0.7%) 
  
7 (1.6%) 




2 (0.4%) 3 (0.7%) 1 (0.2%) 1 (0.2%) 10 (2.2%) 
PwD EQ-5D5L utility 1 (0.2%) 
 
8 (1.8%) 2 (0.4%) 2 (0.4%) 1 (0.2%) 
  
14 (3.1%) 
PwD EQ-5D VAS 1 (0.2%) 1 (0.2%) 5 (1.1%) 1 (0.2%) 1 (0.2%) 4 (0.9%) 
 
6 (1.3%) 19 (4.2%) 




2 (0.4%) 1 (0.2%) 1 (0.2%) 
 
5 (1.1%) 




2 (0.4%) 1 (0.2%) 1 (0.2%) 
 
5 (1.1%) 
PwD (PR) ICECAP utility 
  
6 (1.3%) 1 (0.2%) 3 (0.7%) 3 (0.7%) 
 
2 (0.4%) 15 (3.3%) 
PwD ICECAP utility 2 (0.4%) 
 
20 (4.4%) 3 (0.7%) 4 (0.9%) 2 (0.4%) 
 
1 (0.2%) 32 (7.1%) 




2 (0.4%) 1 (0.2%) 1 (0.2%) 2 (0.4%) 9 (2.0%) 




1 (0.2%) 2 (0.4%) 
 
4 (0.9%) 12 (2.7%) 
PwD DEMQOL utility 1 (0.2%) 
 
11 (2.4%) 3 (0.7%) 5 (1.1%) 1 (0.2%) 1 (0.2%) 5 (1.1%) 27 (6.0%) 
IC CarerQOL utility 2 (0.4%) 
 
7 (1.6%) 2 (0.4%) 3 (0.7%) 2 (0.4%) 2 (0.4%) 
 
18 (4.0%) 




2 (0.4%) 1 (0.2%) 1 (0.2%) 
 
5 (1.1%) 






1 (0.2%) 1 (0.2%) 11 (2.4%) 






1 (0.2%) 1 (0.2%) 11 (2.4%) 






1 (0.2%) 1 (0.2%) 11 (2.4%) 
PwD Acc. Own home 
         
PwD Acc. Intermediate 
         
PwD Acc. Dementia specific 
         
PwD Acc. Long-term institutional 
         
PwD Acc. Other 
         
PwD Hospital admission 
         
PwD Hospital emergency 
  
2 (0.4%) 
     
2 (0.4%) 
PwD Care professional 
         
PwD Service district nurse 1 (0.2%) 
 
1 (0.2%) 




PwD Service home aid 1 (0.2%) 
 
1 (0.2%) 
     
2 (0.4%) 
PwD Service food delivery 1 (0.2%) 
 
1 (0.2%) 
     
2 (0.4%) 
PwD Service day care 
  
1 (0.2%) 
     
1 (0.2%) 
PwD Service transportation 1 (0.2%) 
 
2 (0.4%) 
     
3 (0.7%) 
PwD Service other 3 (0.7%) 
 
1 (0.2%) 1 (0.2%) 
    
5 (1.1%) 
IC Informal care personal ADL 
  
6 (1.3%) 1 (0.2%) 3 (0.7%) 1 (0.2%) 
  
11 (2.4%) 
IC Informal care instrumental ADL 
  
4 (0.9%) 1 (0.2%) 1 (0.2%) 1 (0.2%) 
  
7 (1.6%) 
IC Informal care supervision 
  
4 (0.9%) 1 (0.2%) 2 (0.4%) 1 (0.2%) 
  
8 (1.8%) 
IC Hospital admission 
         




1 (0.2%) 1 (0.2%) 
  
4 (0.9%) 
IC Care professional 
         
IC Productivity losses 1 (0.2%) 
   
1 (0.2%) 
   
2 (0.4%) 




SUPPLEMENTAL 3: Mean resource use (and 5th and 95th percentile) during 30 days prior to baseline using item-wise deletion of 






















































North North West West West West South South 
 
Person with dementia   
   
  
  
Acc. Own home (days) 28.5 (15.0-30.0) 29.7 (28.0-30.0) 28.9 (23.0-30.0) 28.1 (18.0-30.0) 28.0 (0.0-30.0) 29.6 (30.0-30.0) 25.7 (0.0-30.0) 24.4 (0.0-30.0) 27.8 (0.0-30.0) 
Acc. Intermediate (days) 1.5 (0.0-15.0)  0.6 (0.0-0.0) 
 
0.7 (0.0-0.0)    0.3 (0.0-0.0) 
Acc. Dementia specific (days)   
 
0.3 (0.0-0.0)     0.0 (0.0-0.0) 
Acc. Long-term institutional (days)   
  
0.6 (0.0-0.0)    0.1 (0.0-0.0) 
Acc. Other (days)   0.2 (0.0-0.0) 1.2 (0.0-3.0) 0.6 (0.0-0.0) 0.4 (0.0-0.0) 4.2 (0.0-30.0) 5.6 (0.0-30.0) 1.6 (0.0-15.0) 
Hospital admission (nights)  0.3 (0.0-2.0) 0.3 (0.0-3.0) 1.0 (0.0-2.0) 0.1 (0.0-1.0) 0.0 (0.0-0.0) 0.1 (0.0-0.0) 
 
0.2 (0.0-0.0) 
Hospital emergency (visits) 0.0 (0.0-0.0) 0.1 (0.0-1.0) 0.0 (0.0-0.0) 
 
0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.1 (0.0-1.0) 0.1 (0.0-1.0) 0.1 (0.0-0.0) 
Care professional (visits) 0.6 (0.0-2.0) 1.1 (0.0-2.0) 3.0 (0.0-11.0) 1.3 (0.0-4.0) 1.8 (0.0-8.0) 1.8 (0.0-7.0) 1.6 (0.0-5.0) 1.3 (0.0-4.0) 1.6 (0.0-5.0) 
Service district nurse (hours)  0.3 (0.0-2.0) 0.1 (0.0-0.0) 0.4 (0.0-1.0) 0.1 (0.0-0.0) 0.5 (0.0-1.0) 0.1 (0.0-0.0) 0.1 (0.0-0.0) 0.2 (0.0-1.0) 
Service home aid (hours) 0.1 (0.0-2.0) 7.7 (0.0-30.0) 0.1 (0.0-0.0) 
 
1.1 (0.0-5.0) 2.2 (0.0-22.0) 0.1 (0.0-0.0) 0.1 (0.0-0.0) 1.4 (0.0-1.0) 
Service food delivery (visits) 0.4 (0.0-6.0) 5.0 (0.0-30.0) 0.6 (0.0-0.0) 0.8 (0.0-0.0) 1.4 (0.0-12.0) 0.3 (0.0-0.0) 1.7 (0.0-30.0) 1.7 (0.0-20.0) 1.4 (0.0-8.0) 
Service day care (hours) 10.1 (0.0-57.5)  2.5 (0.0-20.0) 0.7 (0.0-0.0) 0.6 (0.0-0.0) 4.1 (0.0-42.0) 4.1 (0.0-0.0) 
 
2.9 (0.0-20.0) 
Service transportation (visits) 2.3 (0.0-22.0)  0.3 (0.0-0.0) 0.1 (0.0-0.0) 0.0 (0.0-0.0) 0.8 (0.0-8.0) 0.0 (0.0-0.0) 
 
0.5 (0.0-1.0) 
Service other (hours) 0.2 (0.0-4.0)  0.6 (0.0-0.0) 1.8 (0.0-15.2) 
 
0.1 (0.0-0.0)  17.9 (0.0-60.0) 2.9 (0.0-4.0)  
  
   
  
  
Informal caregiver   
   
  
  
Informal care PADL (hours) 11 (0-54) 5 (0-33) 45 (0-210) 20 (0-64) 14 (0-75) 43 (0-167) 43 (0-167) 21 (0-86) 26 (0-129) 
Informal care IADL (hours) 82 (1-220) 101 (0-300) 125 (6-300) 59 (0-200) 91 (0-240) 110 (20-240) 101 (0-250) 70 (13-171) 93 (0-240) 
Informal care supervision (hours) 148 (0-410) 12 (0-50) 79 (0-367) 31 (0-144) 132 (0-429) 115 (0-400) 80 (0-360) 30 (0-120) 81 (0-371) 
Hospital admission (nights) 0.2 (0.0-0.0) 0.1 (0.0-0.0) 0.5 (0.0-0.0) 0.1 (0.0-0.0) 0.0 (0.0-0.0) 0.0 (0.0-0.0)  
 
0.1 (0.0-0.0) 
Hospital emergency (visits) 0.1 (0.0-1.0) 0.0 (0.0-0.0) 0.1 (0.0-1.0) 
  
0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.1 (0.0-1.0) 0.0 (0.0-0.0) 
Care professional (visits) 1.0 (0.0-3.0) 0.6 (0.0-2.0) 2.1 (0.0-8.0) 0.9 (0.0-4.0) 1.4 (0.0-5.0) 1.1 (0.0-4.0) 0.6 (0.0-2.0) 1.0 (0.0-3.0) 1.1 (0.0-4.0) 
Productivity losses (hours) 1.2 (0.0-8.6) 10.3 (0.0-40.0) 1.3 (0.0-0.0) 7.4 (0.0-65.7) 2.7 (0.0-8.0) 3.1 (0.0-4.0) 5.7 (0.0-28.0) 0.4 (0.0-4.0) 3.7 (0.0-12.0) 
Empty cells represent no care use, which is different from cell containing 0.0 (0.0-0.0), which represent rounded estimates lower than 0.05.  
Abbreviations: Acc., accommodation; PADL, personal activities of daily living; IADL, instrumental activities of daily living
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Informal care unit price 















































































1 proxy good unit prices (€, 2015): Germany (12.97), Ireland (15.40), Italy (11.09), Netherlands (13.68), Norway (23.27), Portugal (5.14), 




SUPPLEMENTAL 5: Detailed unit prices, sources and assumptions 
supplemental 5.xlsx
 
 
